C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
11/2011
11/03/2011	US20110269783 Novel 2,3-diamino-quinazolinone derivatives and their medical use
11/03/2011	US20110269772 Axl kinase inhibitors
11/03/2011	US20110269761 Arylsulphonylglycine derivatives, the preparation thereof and their use as medicaments
11/03/2011	US20110269760 Tubulin inhibitors
11/03/2011	US20110269736 1,1'-Diadamantyl carboxylic acids, medicaments containing such compounds and their use
11/03/2011	US20110269706 Hydroxamic Acid Derivatives
11/03/2011	US20110269677 Oligomer-Protease Inhibitor Conjugates
11/03/2011	US20110268720 Formulations of 5-fluorocytosine and uses thereof
11/03/2011	CA2800569A1 Cyclopropyl dicarboxamides and analogs exhibiting anti-cancer and anti-proliferative activities
11/02/2011	EP2383262A1 Phenyl pyrimidone compounds, pharmaceutical compositions, preparation methods and uses thereof
11/02/2011	EP2383259A1 New pyridone derivatives with MCH antagonistic activity and medicaments comprising these compounds
11/02/2011	EP2383258A1 Method for rapidly methylating heteroaromatic ring aryl and method for producing pet tracer
11/02/2011	EP2382194A2 Compounds for the prevention and treatment of cardiovascular disease
11/02/2011	EP2382190A1 Toluidine sulfonamides and their use as-inhibitors
11/02/2011	EP2381944A1 Anti-viral compounds, treatment, and assay
11/02/2011	EP2278973B1 Gem-disubstituted and spirocyclic amino pyridines/pyrimidines as cell cycle inhibitors
11/02/2011	EP2170837B1 Process for preparing 2-(3-{6-[2-(2,4-dichlorophenyl)-ethylamino]-2-methoxypyrimidin-4-yl)-phenyl)-2-methylpropionic acid
11/02/2011	CN102229609A Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta
11/02/2011	CN102229605A N-substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase
11/02/2011	CN102229589A N-{4'-substituted piperazine-1-sulfonylmethylalkyl}-N-hydroxyfomamide compounds as metalloproteinase inhibitors
11/02/2011	CN102229572A 3-fluorophenyl-quinazoline-4 (3H)-ketone compound and preparation method thereof
11/02/2011	CN102229571A 5-fluorouracil drug intermediate, preparation method and application thereof
11/02/2011	CN101511798B [4,5']bipyrimidinyl-6,4'-diamine derivatives as protein kinase inhbitors
11/01/2011	USRE42889 α- and β- amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
11/01/2011	US8049010 Using 4-4'-fluorophenyl-6-isopropyl-2-(N-methyl-N-methylsulfonylamino)pyrimidine-5-formaldehyde as raw material; cyanation to 4-4'-fluorophenyl-6-isopropyl-2-(N-methyl-N-methylsulfonylamino)pyrimidine-5-acrylonitrile; carbonylation, chain extension, hydrolysis, neutralization, decomposition, catalysis
11/01/2011	US8048889 3,4-disubstituted coumarin and quinolone compounds
11/01/2011	US8048883 Chronic Myelogenous Leukemia; crystal form stable at room temperature or higher temperatures up to 120 degrees C. and accelerated stress conditions, freely soluble in water; suspending Imatinib base in isopropanol and adding methane sulfonic acid at room temperature then cooling after reactoion
11/01/2011	CA2481261C Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds
11/01/2011	CA2476586C Sulfonyl-derivatives as novel inhibitors of histone deacetylase
11/01/2011	CA2458813C Anti-cancer cyclopenta[g]quinazoline compounds
11/01/2011	CA2458534C Phenethanolamine derivatives for treatment of respiratory diseases
11/01/2011	CA2446193C 1,4-disubstituted benzo-fused cycloalkyl urea compounds
10/2011
10/27/2011	WO2011132633A1 Substituted 5-hydroxypyrimidine-4-carboxamide compound
10/27/2011	WO2011131135A1 Heteroaryl (alkyl) dithiocarbamate compounds, preparation methods and uses thereof
10/27/2011	WO2011130908A1 Substituted pyrimidines
10/27/2011	WO2011065800A3 Pyrimidine derivative, method for preparing same and pharmaceutical composition containing same
10/27/2011	WO2011063072A3 Process for the preparation of substituted phenylalanines
10/27/2011	WO2011054442A3 Materials for electronic devices
10/27/2011	US20110263854 Improved Process For The Preparation Of Endothelin Receptor Antagonists
10/27/2011	US20110263849 Method for rapidly methylating heteroaromatic arene and method for producing tracer for use in pet
10/27/2011	US20110263627 N3-substituted-n1-sulfonyl-5-fluoropyrimidinone derivatives
10/27/2011	US20110263626 Novel bradykinin b1-antagonists
10/27/2011	US20110263625 Hiv replication inhibiting pyrimidines
10/27/2011	US20110263582 Cyclic urea inhibitors of 11 b-hydroxysteroid dehydrogenase 1
10/27/2011	US20110263567 Compounds for inhibiting semicarbazide-sensitive amine oxidase (ssao) / vascular adhesion protein-1 (vap-1) and uses thereof for treatment and prevention of diseases
10/27/2011	US20110263556 New Compounds
10/27/2011	CA2796637A1 Certain amino-pyrimidines, compositions thereof, and methods for their use
10/26/2011	EP2380898A1 Process to make glucocortisoid compounds
10/26/2011	EP2380882A1 Salts of heterocyclic anions and their uses as ionic conductive materials
10/26/2011	EP2380872A1 Polycationic compounds and uses thereof
10/26/2011	EP2379534A1 Heterocyclic antiviral compounds
10/26/2011	EP2379510A1 Quinazolinone compounds
10/26/2011	EP2142504B1 Lactam-substituted dicarboxylic acids and use thereof
10/26/2011	EP1518855B1 Diaminopyrimidinecarboxa mide derivative
10/26/2011	CN102227420A Quinazolinone, quinolone and related analogs as sirtuin modulators
10/26/2011	CN102226210A Tetrahydropyrimidine and method for extracting tetrahydropyrimidine by film technology
10/26/2011	CN102225930A Method of treatment of age-related macular degeneration(AMD)
10/26/2011	CN102225912A Method for synthesizing 3,4-dihydropyrimidine-2(1H)-(sulfur) ketone compound by organic small molecule catalysis
10/26/2011	CN102225910A Preparation method of Bronsted acidic ionic liquid based on isonicotinic acid cation
10/26/2011	CN102225902A Processes for the preparation of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile
10/26/2011	CN101531639B Method for iodinating 5th position of ferric inorganic salt catalyzed 2-pyrimidone and derivatives thereof
10/25/2011	US8044211 P38 MAP kinase inhibitors
10/25/2011	US8044201 Stem cell cultures
10/25/2011	US8044090 N-(2-arylethyl)benzylamines as antagonists of the 5-HT6 receptor
10/25/2011	US8044055 2-phenyl-6-aminocarbonyl-pyrimidine derivatives and their use as P2Y12 receptor
10/25/2011	US8044054 Stereoisomerically enriched 3-aminocarbonyl bicycloheptene pyrimidinediamine compounds and their uses
10/25/2011	US8044053 Sulfonamide substituted pyrazoline compounds, their preparation and use as CB1 modulators
10/25/2011	US8044040 e.g. 3-{3-Cyano-6-[(2,2-dimethyl-propyl)-methyl-amino]-5-fluoro-pyridin-2-ylamino}-N-methoxy-4-methyl-benzamide; via p38 kinase inhibition; (anilino)(halo)pyrimidine or (anilino)(amino)pyrimidine derivatives; rheumatoid arthritis, psoriasis, Crohn's Disease, osteoarthritis or osteoporosis
10/20/2011	WO2011128618A1 Co -crystals of pyrimethanil or cyprodinil
10/20/2011	US20110257391 Process for production of quinazoline derivative
10/20/2011	US20110257199 Novel teraryl compounds as antiparasitic agents
10/20/2011	US20110257196 Compounds for treatment of cancer
10/20/2011	US20110257154 Compounds and compositions as protein kinase inhibitors
10/19/2011	EP2377854A1 N-phenyl-dioxo-hydropyrimidines useful as hepatitis C virus (HCV) inhibitors
10/19/2011	EP2377539A1 Quinazoline analogs as receptor tyrosine kinase inhibitors
10/19/2011	EP2376511A2 Bicyclic derivatives of morphine-6-glucuronid, process for their preparation and their application in therapy
10/19/2011	EP2376083A1 Quinazoline inhibitors of bace 1 and methods of using
10/19/2011	EP2004607B1 (4-(4-[6-(trifluoromethyl-pyridin-3-ylamino)-N-containing-heteroaryl]-phenyl)-cyclohexyl)-acetic acid derivatives and pharmaceutical uses thereof
10/19/2011	EP1926716B1 Process for synthesis of aryloxy diaminopyrimidines
10/19/2011	EP1694651B1 Herbicidal pyrimidines
10/19/2011	CN102224217A Electroluminescent device using the electroluminescent compounds
10/19/2011	CN102224144A Sulfone-substituted anilinopyrimidine derivatives as cdk inhibitors, the production thereof, and use as a medicine
10/19/2011	CN102219751A Pentadienone-containing 4-substituted quinazoline derivative, preparation method and use thereof
10/19/2011	CN102219750A N-substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase
10/19/2011	CN102219749A Method for preparing rosuvastatin calcium
10/19/2011	CN102219748A Amorphous Ambrisentan and preparation method thereof
10/19/2011	CN101570515B Curcumin substituted uracil derivative, preparation method and use thereof
10/19/2011	CN101421251B 4,5-diphenyl-pyrimidinyl-amino substituted carboxylic acids, method for the production and use thereof as medicaments
10/18/2011	US8039479 Compounds and compositions as protein kinase inhibitors
10/18/2011	US8039478 Purinone derivatives as HM74A agonists
10/18/2011	CA2398018C Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
10/13/2011	WO2011127388A2 Inverse agonists and neutral antagonists for the tsh receptor
10/13/2011	WO2011126224A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
10/13/2011	WO2011079343A3 Substituted pyridines and pyrimidines for the production of cardiomyocyte - like cells
10/13/2011	WO2010115950A3 Process for the preparation of pyrimidine derivatives
10/13/2011	US20110251222 Sulfone-substituted anilinopyrimidine derivatives as cdk inhibitors, the production thereof, and use as a medicine
10/13/2011	US20110251220 Pharmaceutical compositions comprising gamma secretase modulators
10/13/2011	US20110251200 Aryl guanidine f1f0-atpase inhibitors and related methods
10/13/2011	US20110251181 5h-cyclopenta[d]pyrimidines as akt protein kinase inhibitors
10/13/2011	US20110251174 2,4-diamino-pyrimidines as aurora inhibitors

1 ... 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 ... 427